FMC downgraded at RBC Capital; shares plunge on weak outlook
FMC (NYSE:FMC) on Wednesday was downgraded to Sector Perform from a previous investment rating of Outperform by analysts at ...
Hosted on MSN1h
RBC Capital Downgrades FMC (FMC)
Fintel reports that on February 5, 2025, RBC Capital downgraded their outlook for FMC (NYSE:FMC) from Outperform to Sector ...
RBC Capital Reaffirms Their Buy Rating on Moody’s (MCO)
RBC Capital analyst Ashish Sabadra maintained a Buy rating on Moody’s (MCO – Research Report) on February 4 and set a price target of $550.00.
bovnews16h
Why Did RBC Capital Mkts Give SAGE Therapeutics Inc (SAGE) Stock Sector Perform Rating?
RBC Capital Mkts has recently raised SAGE Therapeutics Inc (SAGE) stock to Sector Perform rating, as announced on November 21, 2024, according to Finviz. Earlier, on October 10, 2 ...
Seeking Alpha29d
RBC Capital scoffs at critics with Carvana upgrade
Acknowledging that there is skepticism surrounding its business model and ability to sustain profitability targets, RBC Capital joins the growing list of bulls in support of Carvana, raising its ...
RBC Capital Remains a Buy on S&P Global (SPGI)
RBC Capital analyst Ashish Sabadra maintained a Buy rating on S&P Global (SPGI – Research Report) on February 4 and set a price target of ...
Sarepta could be down on patient death in FDA database, says RBC Capital
RBC Capital analyst Brian Abrahams says shares of Sarepta (SRPT) could be trading lower today on an FDA database update that ...
RBC cuts Atkore stock price target to $73 from $91
RBC Capital Markets adjusted its outlook on Atkore International Group Inc . (NYSE: NYSE:ATKR), reducing the company's price target from $91.00 to $73.00 while maintaining a Sector Perform rating.